<code id='D5A3A5714B'></code><style id='D5A3A5714B'></style>
    • <acronym id='D5A3A5714B'></acronym>
      <center id='D5A3A5714B'><center id='D5A3A5714B'><tfoot id='D5A3A5714B'></tfoot></center><abbr id='D5A3A5714B'><dir id='D5A3A5714B'><tfoot id='D5A3A5714B'></tfoot><noframes id='D5A3A5714B'>

    • <optgroup id='D5A3A5714B'><strike id='D5A3A5714B'><sup id='D5A3A5714B'></sup></strike><code id='D5A3A5714B'></code></optgroup>
        1. <b id='D5A3A5714B'><label id='D5A3A5714B'><select id='D5A3A5714B'><dt id='D5A3A5714B'><span id='D5A3A5714B'></span></dt></select></label></b><u id='D5A3A5714B'></u>
          <i id='D5A3A5714B'><strike id='D5A3A5714B'><tt id='D5A3A5714B'><pre id='D5A3A5714B'></pre></tt></strike></i>

          focus

          focus

          author:Wikipedia    Page View:5938
          Christine Kao/STAT

          There’s a specter haunting Wall Street.

          It started in biotech, where companies making drugs for the obesity-related liver disease NASH saw their valuations crash on the assumption that GLP-1 weight loss treatments would cut them out of the market. Then the Ozempic panic came for dialysis firms, whose stocks fell about 20% in a single day on the news that Novo Nordisk’s medicine had delayed the progression of kidney disease in a study enrolling people with type 2 diabetes.

          advertisement

          Now analysts from every sector are cranking out research notes on the disparate, dramatic, and often debatable implications of GLP-1 drugs’ growing popularity, said Jared Holz, a health care specialist at Mizuho Securities. Buy Bumble, sell McDonald’s. Short Pepsi, go long Louis Vuitton. Put your money in sectors that cater to a svelte and sated brand of consumer, and get out of the ones that rely on excess and compulsion.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          Racing yachts have close encounter with pod of orcas near Strait of Gibraltar
          Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

          1:30Twosixty-five-footraceyachtshadacloseencounterwithorcawhalesastheyapproachedtheStraitofGibraltar

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          Asbestos, a deadly carcinogen, banned by EPA

          EPAAdministratorMichaelReganspeaksonFeb.16,2024,inEastPalestine,Ohio.TheEPAhasannouncedacomprehensiv